Literature DB >> 30021858

Gabapentin Is a Potent Activator of KCNQ3 and KCNQ5 Potassium Channels.

Rían W Manville1, Geoffrey W Abbott2.   

Abstract

Synthetic gabapentinoids, exemplified by gapapentin and pregabalin, are in extensive clinical use for indications including epilepsy, neuropathic pain, anxiety, and alcohol withdrawal. Their mechanisms of action are incompletely understood, but are thought to involve inhibition of α2δ subunit-containing voltage-gated calcium channels. Here, we report that gabapentin is a potent activator of the heteromeric KCNQ2/3 voltage-gated potassium channel, the primary molecular correlate of the neuronal M-current, and also homomeric KCNQ3 and KCNQ5 channels. In contrast, the structurally related gabapentinoid, pregabalin, does not activate KCNQ2/3, and at higher concentrations (≥10 µM) is inhibitory. Gabapentin activation of KCNQ2/3 (EC50 = 4.2 nM) or homomeric KCNQ3* (EC50 = 5.3 nM) channels requires KCNQ3-W265, a conserved tryptophan in KCNQ3 transmembrane segment 5. Homomeric KCNQ2 or KCNQ4 channels are insensitive to gabapentin, whereas KCNQ5 is highly sensitive (EC50 = 1.9 nM). Given the potent effects and the known anticonvulsant, antinociceptive, and anxiolytic effects of M-channel activation, our findings suggest the possibility of an unexpected role for M-channel activation in the mechanism of action of gabapentin.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30021858      PMCID: PMC6108572          DOI: 10.1124/mol.118.112953

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  51 in total

1.  Targeted disruption of the voltage-dependent calcium channel alpha2/delta-1-subunit.

Authors:  Geraldine A Fuller-Bicer; Gyula Varadi; Sheryl E Koch; Masakazu Ishii; Ilona Bodi; Nijiat Kadeer; James N Muth; Gabor Mikala; Natalia N Petrashevskaya; Michael A Jordan; Sui-Po Zhang; Ning Qin; Christopher M Flores; Idit Isaacsohn; Maria Varadi; Yasuo Mori; W Keith Jones; Arnold Schwartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-08       Impact factor: 4.733

2.  KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel.

Authors:  H S Wang; Z Pan; W Shi; B S Brown; R S Wymore; I S Cohen; J E Dixon; D McKinnon
Journal:  Science       Date:  1998-12-04       Impact factor: 47.728

3.  Fast docking using the CHARMM force field with EADock DSS.

Authors:  Aurélien Grosdidier; Vincent Zoete; Olivier Michielin
Journal:  J Comput Chem       Date:  2011-05-03       Impact factor: 3.376

4.  The effects of gabapentin on different ligand- and voltage-gated currents in isolated cortical neurons.

Authors:  A Stefani; F Spadoni; P Giacomini; F Lavaroni; G Bernardi
Journal:  Epilepsy Res       Date:  2001-03       Impact factor: 3.045

5.  Cloning and deletion mutagenesis of the alpha2 delta calcium channel subunit from porcine cerebral cortex. Expression of a soluble form of the protein that retains [3H]gabapentin binding activity.

Authors:  J P Brown; N S Gee
Journal:  J Biol Chem       Date:  1998-09-25       Impact factor: 5.157

6.  Modulation of K+-evoked [3H]-noradrenaline release from rat and human brain slices by gabapentin: involvement of KATP channels.

Authors:  T M Freiman; J Kukolja; J Heinemeyer; K Eckhardt; H Aranda; A Rominger; D J Dooley; J Zentner; T J Feuerstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-05       Impact factor: 3.000

7.  Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin.

Authors:  E Ben-Menachem; L I Persson; T Hedner
Journal:  Epilepsy Res       Date:  1992-03       Impact factor: 3.045

8.  Seizure frequency and CSF parameters in a double-blind placebo controlled trial of gabapentin in patients with intractable complex partial seizures.

Authors:  E Ben-Menachem; B Söderfelt; A Hamberger; T Hedner; L I Persson
Journal:  Epilepsy Res       Date:  1995-07       Impact factor: 3.045

9.  SwissDock, a protein-small molecule docking web service based on EADock DSS.

Authors:  Aurélien Grosdidier; Vincent Zoete; Olivier Michielin
Journal:  Nucleic Acids Res       Date:  2011-05-29       Impact factor: 16.971

10.  The α2δ-1-NMDA Receptor Complex Is Critically Involved in Neuropathic Pain Development and Gabapentin Therapeutic Actions.

Authors:  Jinjun Chen; Lingyong Li; Shao-Rui Chen; Hong Chen; Jing-Dun Xie; Rita E Sirrieh; David M MacLean; Yuhao Zhang; Meng-Hua Zhou; Vasanthi Jayaraman; Hui-Lin Pan
Journal:  Cell Rep       Date:  2018-02-27       Impact factor: 9.423

View more
  16 in total

1.  Synthesis and Optimization of Kv7 (KCNQ) Potassium Channel Agonists: The Role of Fluorines in Potency and Selectivity.

Authors:  Ruiting Liu; Thanos Tzounopoulos; Peter Wipf
Journal:  ACS Med Chem Lett       Date:  2019-05-08       Impact factor: 4.345

2.  KCNQ/M-channels regulate mouse vagal bronchopulmonary C-fiber excitability and cough sensitivity.

Authors:  Hui Sun; An-Hsuan Lin; Fei Ru; Mayur J Patil; Sonya Meeker; Lu-Yuan Lee; Bradley J Undem
Journal:  JCI Insight       Date:  2019-03-07

3.  Results from a randomized, double-blind, placebo-controlled, crossover, multimodal-MRI pilot study of gabapentin for co-occurring bipolar and cannabis use disorders.

Authors:  James J Prisciandaro; William Mellick; Lindsay M Squeglia; Sara Hix; Lauren Arnold; Bryan K Tolliver
Journal:  Addict Biol       Date:  2021-08-14       Impact factor: 4.093

4.  Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes.

Authors:  Ilaria Mosca; Ilaria Rivolta; Audrey Labalme; Paolo Ambrosino; Barbara Castellotti; Cinzia Gellera; Tiziana Granata; Elena Freri; Anna Binda; Gaetan Lesca; Jacopo C DiFrancesco; Maria Virginia Soldovieri; Maurizio Taglialatela
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

5.  Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine.

Authors:  Rían W Manville; Geoffrey W Abbott
Journal:  J Pharmacol Exp Ther       Date:  2020-03-26       Impact factor: 4.030

Review 6.  Chemical modulation of Kv7 potassium channels.

Authors:  Matteo Borgini; Pravat Mondal; Ruiting Liu; Peter Wipf
Journal:  RSC Med Chem       Date:  2021-01-14

7.  Cilantro leaf harbors a potent potassium channel-activating anticonvulsant.

Authors:  Rían W Manville; Geoffrey W Abbott
Journal:  FASEB J       Date:  2019-07-16       Impact factor: 5.834

Review 8.  Pharmacological Manipulation of K v 7 Channels as a New Therapeutic Tool for Multiple Brain Disorders.

Authors:  Fabio A Vigil; Chase M Carver; Mark S Shapiro
Journal:  Front Physiol       Date:  2020-06-19       Impact factor: 4.566

9.  Effects of Gabapentin on Dorsal Anterior Cingulate Cortex GABA and Glutamate Levels and Their Associations With Abstinence in Alcohol Use Disorder: A Randomized Clinical Trial.

Authors:  James J Prisciandaro; Michaela Hoffman; Truman R Brown; Konstantin Voronin; Sarah Book; Emily Bristol; Raymond F Anton
Journal:  Am J Psychiatry       Date:  2021-07-14       Impact factor: 19.242

10.  Deconstruction of an African folk medicine uncovers a novel molecular strategy for therapeutic potassium channel activation.

Authors:  Angele M De Silva; Rían W Manville; Geoffrey W Abbott
Journal:  Sci Adv       Date:  2018-11-14       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.